OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
Lingyue Liu, Xing Huang, Fukang Shi, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 59
Lingyue Liu, Xing Huang, Fukang Shi, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems
Zhongying Gong, Shan Peng, Juanjuan Cao, et al.
Nanotechnology (2024) Vol. 35, Iss. 13, pp. 132001-132001
Closed Access | Times Cited: 9
Zhongying Gong, Shan Peng, Juanjuan Cao, et al.
Nanotechnology (2024) Vol. 35, Iss. 13, pp. 132001-132001
Closed Access | Times Cited: 9
Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance
Ting Li, Lianshan Guo, Jiaxu Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1249-1272
Open Access | Times Cited: 7
Ting Li, Lianshan Guo, Jiaxu Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1249-1272
Open Access | Times Cited: 7
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 6
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 6
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
Qihan Fu, Yiwen Chen, Dabing Huang, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 8, pp. 5071-5080
Closed Access | Times Cited: 13
Qihan Fu, Yiwen Chen, Dabing Huang, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 8, pp. 5071-5080
Closed Access | Times Cited: 13
Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review
Gengyu Sha, Wenjie Zhang, Zhengting Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130149-130149
Closed Access | Times Cited: 5
Gengyu Sha, Wenjie Zhang, Zhengting Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130149-130149
Closed Access | Times Cited: 5
In vitro and in vivo experimental models for cancer immunotherapy study
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100210-100210
Open Access | Times Cited: 4
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100210-100210
Open Access | Times Cited: 4
Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Manxiu Huai, Yingjie Wang, Junhao Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Manxiu Huai, Yingjie Wang, Junhao Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4
Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Managing adverse effects of novel immunotherapies in pancreatic and colon cancers
Zohaib Ahmed, Zahoor Ahmad, Sarfraz Ahmad
Elsevier eBooks (2025), pp. 341-361
Closed Access
Zohaib Ahmed, Zahoor Ahmad, Sarfraz Ahmad
Elsevier eBooks (2025), pp. 341-361
Closed Access
A Systematic Review of Vitamin D Supplementation in Oncology: Chance of Science or Effectiveness?
M. Afonso, Manuel Luís Capelas, Nuno Pimenta, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 634-634
Open Access
M. Afonso, Manuel Luís Capelas, Nuno Pimenta, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 634-634
Open Access
Integrin αvβ3-Targeted Therapeutic Strategies in Pancreatic Cancers
Zi-Lin Li, Ya‐Jung Shih, Chung‐Che Tsai, et al.
IntechOpen eBooks (2025)
Closed Access
Zi-Lin Li, Ya‐Jung Shih, Chung‐Che Tsai, et al.
IntechOpen eBooks (2025)
Closed Access
Novel CXCR2 antibodies exhibit enhanced anti-tumor activity in pancreatic cancer
Parastou Rahimizadeh, Se Heon Kim, Bo Hyun Yoon, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117966-117966
Closed Access
Parastou Rahimizadeh, Se Heon Kim, Bo Hyun Yoon, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117966-117966
Closed Access
Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model
Han V. Han, Richard Efem, Barbara Rosati, et al.
eLife (2025) Vol. 13
Open Access
Han V. Han, Richard Efem, Barbara Rosati, et al.
eLife (2025) Vol. 13
Open Access
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
Miaomiao Chen, Yuli Zhou, Kelvin K H Bao, et al.
BioDrugs (2025)
Closed Access
Miaomiao Chen, Yuli Zhou, Kelvin K H Bao, et al.
BioDrugs (2025)
Closed Access
In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma
Udit Basak, Sumon Mukherjee, Sourio Chakraborty, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Udit Basak, Sumon Mukherjee, Sourio Chakraborty, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cytokine-based immunotherapy in pancreatic cancer
Andrés Gordo-Ortiz, Inés Ortiz-de-Solórzano, Flor Navarro
International review of cell and molecular biology (2025)
Closed Access
Andrés Gordo-Ortiz, Inés Ortiz-de-Solórzano, Flor Navarro
International review of cell and molecular biology (2025)
Closed Access
Combined Immune Checkpoint Blockade and Helixor® Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW)
Anja Thronicke, Patricia Grabowski, J.A.D.M. De Roos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3669-3669
Open Access
Anja Thronicke, Patricia Grabowski, J.A.D.M. De Roos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3669-3669
Open Access
Efficacy of LNP@2DG-DON liposomal nanoparticles in tumor inhibition and immune activation
Jianang Li, Jiale Feng, Runjie Liu, et al.
(2025)
Closed Access
Jianang Li, Jiale Feng, Runjie Liu, et al.
(2025)
Closed Access
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy
Wenxin Lu, Guangyu Wu, Xianyuan Miao, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 3
Wenxin Lu, Guangyu Wu, Xianyuan Miao, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 3
PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
Kai Wang, Lili Yan, Xun Qiu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167236-167236
Closed Access | Times Cited: 3
Kai Wang, Lili Yan, Xun Qiu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167236-167236
Closed Access | Times Cited: 3
